Chronic kidney disease
Download 353.83 Kb. Pdf ko'rish
|
levey2012
- Bu sahifa navigatsiya:
- Document Outline
53 (suppl 3): S107–14.
141 Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in US adults: a cost-eff ectiveness analysis. JAMA 2003; 290: 3101–14. 142 Hoerger TJ, Wittenborn JS, Segel JE, et al, for the Centers for Disease Control and Prevention CKD Initiative. A health policy model of CKD: 2. The cost-eff ectiveness of microalbuminuria screening. Am J Kidney Dis 2010; 55: 463–73. 143 Manns B, Hemmelgarn B, Tonelli M, et al, for the Alberta Kidney Disease Network. Population based screening for chronic kidney disease: cost eff ectiveness study. BMJ 2010; 341: c5869. 144 Asselbergs FW, Diercks GF, Hillege HL, et al, for the Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators. Eff ects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation 2004; 110: 2809–16. Document Outline
Download 353.83 Kb. Do'stlaringiz bilan baham: |
Ma'lumotlar bazasi mualliflik huquqi bilan himoyalangan ©fayllar.org 2024
ma'muriyatiga murojaat qiling
ma'muriyatiga murojaat qiling